AI drug discovery startup BenevolentAI cuts 30% of staff, closes US office
BenevolentAI is making its second round of layoffs in a year, as the company continues to refine the business strategy around its AI drug discovery …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.